ROBERT GORDON KALB
Medical Practice in Philadelphia, PA

License number
Pennsylvania MD418931
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19147

Professional information

Robert G Kalb Photo 1

Robert G Kalb, Philadelphia PA

Specialties:
Neurologist
Address:
3400 Spruce St, Philadelphia, PA 19104
3401 Civic Center Blvd, Philadelphia, PA 19104
Education:
Cornell University, Weill Cornell Medical College - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Residency - Neurology
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)


Robert Kalb Photo 2

Robert Kalb, Philadelphia PA

Work:
Philadelphia Veterans Affairs Medical Center
3900 Woodland Ave, Philadelphia, PA 19104 Childrens Health Care Associates Inc
34Th St, Philadelphia, PA 19104


Robert G Kalb Photo 3

Dr. Robert G Kalb, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Neurology
Address:
3401 Civic Center Blvd, Philadelphia 19104
(215) 590-1719 (Phone), (215) 590-1771 (Fax)
Languages:
English
Hospitals:
3401 Civic Center Blvd, Philadelphia 19104
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Weill Cornell Medical College
Graduated: 1982
Montefiore M C H&L Moses Division
Yale New Haven Chldn Center


Robert Kalb Photo 4

Godhead At The Childrens Hospital Of Philadelphia

Position:
Godhead at The Childrens Hospital of Philadelphia
Location:
Greater Philadelphia Area
Industry:
Research
Work:
The Childrens Hospital of Philadelphia - Godhead


Robert Kalb Photo 5

Compositions And Methods For Inhibiting Neurodegeneration

US Patent:
2007003, Feb 15, 2007
Filed:
Aug 8, 2006
Appl. No.:
11/500772
Inventors:
Robert Kalb - Philadelphia PA, US
Jelena Mojsilovic-Petrovic - Philadelphia PA, US
International Classification:
A61K 31/522
US Classification:
514263330, 514263340, 514263350
Abstract:
Methods effective for inhibiting neuronal degeneration, particularly in ALS patients are disclosed. Also provided are screening assays for identifying such agents.